Head of the Scientific Advice Office of the European Medicines Agency
Iordanis Gravanis holds a medical degree from the University of Ioannina, Greece and a PhD in Molecular and Cellular Pharmacology from Stony Brook University, NY, USA. His thesis research revolved around neurodegenerative models of excitotoxicity in mice. He joined the EMA in 2008 and worked initially in the Oncology, Haematology and Diagnostics Section as EMA Product Team Leader for centralised marketing authorization applications and post-authorisation lifecycle applications. In 2014, he moved to the Procedure Management Department supporting the improvement of the medicines authorisation and post-authorisation processes and the EMA IT tools which support such processes. Since 2020, he has been heading the Scientific Advice Office which supports scientific advice/protocol assistance including the qualification of novel methodologies, parallel scientific advice with health technology assessment bodies and scientific advice for public health emergencies.